Patents by Inventor Patricia S. Walker

Patricia S. Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Botulinum toxin administration to treat various conditions
    Patent number: 8420105
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Grant
    Filed: August 18, 2011
    Date of Patent: April 16, 2013
    Assignee: Allergan, Inc.
    Inventor: Patricia S. Walker
  • Botulinum Toxin Administration to Treat Various Conditions
    Publication number: 20120114703
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Application
    Filed: August 18, 2011
    Publication date: May 10, 2012
    Applicant: ALLERGAN, INC.
    Inventor: Patricia S. Walker
  • Botulinum toxin administration to treat various conditions
    Patent number: 8025889
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Grant
    Filed: December 19, 2008
    Date of Patent: September 27, 2011
    Assignee: Allergan, Inc.
    Inventor: Patricia S. Walker
  • CLINICAL ASSESSMENT SCALES AND METHODS
    Publication number: 20110160617
    Abstract: Disclosed herein are scales for assessing lip fullness, severity of perioral lines at rest, severity of perioral lines at maximum contraction or oral commissures. The scales comprise rows or columns of photographs corresponding to different severity categories. Each scale may have a Kappa score of at least about 0.700 for intra-rater and inter-rater reliability.
    Type: Application
    Filed: October 22, 2009
    Publication date: June 30, 2011
    Applicant: ALLERGAN, INC.
    Inventors: Jane A. Thomas, Patricia S. Walker
  • BOTULINUM TOXIN ADMINISTRATION TO TREAT VARIOUS CONDITIONS
    Publication number: 20100272754
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Application
    Filed: December 19, 2008
    Publication date: October 28, 2010
    Applicant: ALLERGAN, INC.
    Inventor: Patricia S. WALKER
  • CLINICAL ASSESSMENT SCALES AND METHODS
    Publication number: 20100137747
    Abstract: Disclosed herein are scales for assessing lip fullness, severity of perioral lines at rest, severity of perioral lines at maximum contraction or oral commissures. The scales comprise rows or columns of photographs corresponding to different severity categories. Each scale may have a Kappa score of at least about 0.700 for intra-rater and inter-rater reliability.
    Type: Application
    Filed: October 22, 2009
    Publication date: June 3, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Jane A. Thomas, Patricia S. Walker
  • BOTULINUM TOXIN FOR TREATING POSTHERPETIC NEURALGIA
    Publication number: 20090041805
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Application
    Filed: October 4, 2006
    Publication date: February 12, 2009
    Applicant: ALLERGAN, INC.
    Inventor: PATRICIA S. WALKER
  • Botulinum toxin for treating postherpetic neuralgia
    Patent number: 7479281
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Grant
    Filed: October 4, 2006
    Date of Patent: January 20, 2009
    Assignee: Allergan, Inc.
    Inventor: Patricia S. Walker
  • Methods of administering botulinum toxin
    Patent number: 7255865
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Grant
    Filed: January 17, 2002
    Date of Patent: August 14, 2007
    Assignee: Allergan, Inc.
    Inventor: Patricia S. Walker
  • Methods of administering botulinum toxin
    Publication number: 20020107199
    Abstract: Methods for treating conditions in an animal or human subject. The conditions may be pain, skeletal muscle conditions, smooth muscle conditions, glandular conditions and cosmetic conditions. The methods comprise the step of administering a Clostridium neurotoxin component or Clostridium neurotoxin component encoding DNA to the subject using a needleless syringe.
    Type: Application
    Filed: January 17, 2002
    Publication date: August 8, 2002
    Applicant: Allergan Sales, Inc.
    Inventor: Patricia S. Walker
  • Methods for treating hyperhidrosis
    Publication number: 20020086036
    Abstract: Methods for treating hyperhidrosis is disclosed herein. In one embodiment, the method includes a step of administering a neurotoxin to a skin area to alleviate excessive sweating. In another embodiment, the method employs a needleless injector to affect the administration of a neurotoxin, for example botulinum toxin type A.
    Type: Application
    Filed: December 5, 2000
    Publication date: July 4, 2002
    Applicant: Allergan Sales, Inc.
    Inventor: Patricia S. Walker